Apyx Medical Co. (NASDAQ:APYX) Sees Large Decrease in Short Interest

Apyx Medical Co. (NASDAQ:APYX) was the target of a significant drop in short interest during the month of August. As of August 31st, there was short interest totalling 265,100 shares, a drop of 10.7% from the August 15th total of 296,900 shares. Approximately 0.9% of the company’s shares are short sold. Based on an average daily volume of 34,900 shares, the days-to-cover ratio is presently 7.6 days.

Wall Street Analyst Weigh In

Separately, JMP Securities restated a “market perform” rating on shares of Apyx Medical in a report on Monday.

Apyx Medical Stock Down 7.8 %

Shares of APYX stock opened at $1.07 on Tuesday. The stock has a 50 day moving average of $1.27 and a 200 day moving average of $1.44. Apyx Medical has a twelve month low of $0.97 and a twelve month high of $4.00. The stock has a market cap of $37.07 million, a P/E ratio of -1.62 and a beta of 1.20. The company has a current ratio of 5.33, a quick ratio of 4.45 and a debt-to-equity ratio of 2.26.

Apyx Medical (NASDAQ:APYX) last posted its quarterly earnings results on Thursday, August 8th. The company reported ($0.19) earnings per share for the quarter, missing analysts’ consensus estimates of ($0.18) by ($0.01). The business had revenue of $12.15 million for the quarter, compared to analyst estimates of $12.67 million. Apyx Medical had a negative return on equity of 105.45% and a negative net margin of 57.86%. During the same quarter in the previous year, the firm posted ($0.11) earnings per share. As a group, sell-side analysts expect that Apyx Medical will post -0.69 EPS for the current year.

Hedge Funds Weigh In On Apyx Medical

Hedge funds have recently made changes to their positions in the stock. Kingsview Wealth Management LLC acquired a new stake in shares of Apyx Medical in the fourth quarter valued at $32,000. Worth Venture Partners LLC raised its position in Apyx Medical by 12.0% in the 4th quarter. Worth Venture Partners LLC now owns 518,198 shares of the company’s stock valued at $1,358,000 after purchasing an additional 55,592 shares during the last quarter. ProVise Management Group LLC acquired a new position in Apyx Medical in the fourth quarter valued at $35,000. AIGH Capital Management LLC grew its holdings in shares of Apyx Medical by 7.7% during the fourth quarter. AIGH Capital Management LLC now owns 2,040,540 shares of the company’s stock worth $5,346,000 after buying an additional 145,309 shares during the last quarter. Finally, Silverberg Bernstein Capital Management LLC increased its position in Apyx Medical by 1.2% in the 1st quarter. Silverberg Bernstein Capital Management LLC now owns 621,387 shares of the company’s stock valued at $845,000 after acquiring an additional 7,507 shares during the period. Hedge funds and other institutional investors own 55.33% of the company’s stock.

About Apyx Medical

Apyx Medical Corporation, an energy technology company, engages in the design, development, and manufacture of medical devices in the United States and internationally. The company operates through two segments: Advanced Energy and Original Equipment Manufacturing (OEM). It offers Helium Plasma Generator for delivery of RF energy and helium plasma to cut, coagulate, and ablate soft tissue during open and minimally invasive surgical procedures.